Ambient Ultrafine Particulate Matter and Clinical Outcomes in Fibrotic Interstitial Lung Disease.

air pollution idiopathic pulmonary fibrosis interstitial lung disease ultrafine particulate matter

Journal

American journal of respiratory and critical care medicine
ISSN: 1535-4970
Titre abrégé: Am J Respir Crit Care Med
Pays: United States
ID NLM: 9421642

Informations de publication

Date de publication:
29 Nov 2023
Historique:
medline: 29 11 2023
pubmed: 29 11 2023
entrez: 29 11 2023
Statut: aheadofprint

Résumé

Particulate matter ≤2.5μm (PM To evaluate UFP associations with clinical outcomes in fILD. Multicenter, prospective cohort study enrolling patients with fILD from the University of Pittsburgh Simmons Center and Pulmonary Fibrosis Foundation Patient Registry (PFF-PR). Using a national-scale UFP model, we linked exposures using three approaches in Simmons (residential address geocoordinates, zip centroid geocoordinates, zip average) and two in PFF-PR where only 5-digit zip code was available (zip centroid, zip average). We tested UFP associations with transplant-free survival using multivariable Cox, baseline percent predicted forced vital capacity (FVC) and diffusion capacity of the lung (D Annual mean outdoor UFP levels for 2017 were estimated for 1416 Simmons and 1919 PFF-PR patients. Increased UFP level was associated with transplant-free survival in fully-adjusted Simmons residential address models (HR=1.08 per 1000 particles/cm Increased UFP exposure was associated with transplant-free survival and lung function in the cohort with precise residential location linkage. This work highlights the need for more robust regulatory networks to study the health effects of UFPs nationwide.

Identifiants

pubmed: 38019094
doi: 10.1164/rccm.202307-1275OC
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Auteurs

Gillian C Goobie (GC)

The University of British Columbia Faculty of Medicine, 12358, Division of Respiratory Medicine, Vancouver, British Columbia, Canada.
The University of British Columbia Centre for Heart Lung Innovation, 539747, Vancouver, British Columbia, Canada.
University of Pittsburgh School of Medicine, 12317, Division of Pulmonary, Allergy and Critical Care Medicine, Pittsburgh, Pennsylvania, United States; gcgoobie@alumni.ubc.ca.

Provat K Saha (PK)

Carnegie Mellon University, 6612, Center for Atmospheric Particle Studies, Pittsburgh, Pennsylvania, United States.
Carnegie Mellon University, 6612, Department of Mechanical Engineering, Pittsburgh, Pennsylvania, United States.
Bangladesh University of Engineering and Technology, 61750, Department of Civil Engineering, Dhaka, Dhaka District, Bangladesh.

Christopher Carlsten (C)

University of British Columbia, Medicine, Vancouver, British Columbia, Canada.

Kevin F Gibson (KF)

University of Pittsburgh School of Medicine, Dorothy P. and Richard P. Simmons Center for Interstitial Lung Disease, Pittsburgh, Pennsylvania, United States.

Kerri A Johannson (KA)

University of Calgary, Medicine, Calgary, Alberta, Canada.

Daniel J Kass (DJ)

University of Pittsburgh and the Dorothy P. and Richard P. Simmons Center for Interstitial Lung Disease, Medicine, Pittsburgh, Pennsylvania, United States.

Christopher J Ryerson (CJ)

University of British Columbia, Medicine, Vancouver, British Columbia, Canada.

Yingze Zhang (Y)

University of Pittsburgh, Medicine, Pittsburgh, Pennsylvania, United States.

Allen L Robinson (AL)

Carnegie Mellon University, 6612, Engineering and Public Policy, Pittsburgh, Pennsylvania, United States.

Albert A Presto (AA)

Carnegie Mellon University, 6612, Center for Atmospheric Particle Studies, Department of Mechanical Engineering, Pittsburgh, Pennsylvania, United States.

S Mehdi Nouraie (SM)

University of Pittsburgh and the Dorothy P. and Richard P. Simmons Center for Interstitial Lung Disease, Medicine, Pittsburgh, Pennsylvania, United States.

Classifications MeSH